# 此超級綜合評級是基於以下評級的加權平均結果。

*biotech · news · 2026-05-27 · MarketScreener*

## Key points

- Trader 超級評級使用強調四個月期間內每股盈餘修正的加權平均。
- Investor 超級綜合評級獨特地包含一年期的每股盈餘修正時間範圍於其計算中。
- 全球評級僅在至少涵蓋五個組成評級中的四個時才計算。
- 品質綜合評級要求在報酬率、獲利能力及財務健康三項指標中至少涵蓋兩項。

Trader This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions. Investor This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions. Global This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions. Quality This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.

[Read the full story on MarketScreener](https://www.marketscreener.com/news/corcept-to-resubmit-nda-for-relacorilant-as-treatment-for-cushing-s-syndrome-patients-ce7f5ad3d980f627)

---

Canonical: https://newsio.io/zh-TW/n/7a602803-ef57-42ca-b7f3-9ba815718add/
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works